배성호 (Brigham and Women’s Hospital and Harvard Medical School)님 | 한빛사연구자 > 한빛사

Brigham and Women’s Hospital and Harvard Medical School

CV File

응용의학

최종업데이트 2025.08.28.

- ( 현재 등록 진행중입니다. )
- 배성호(Brigham and Women’s Hospital and Harvard Medical School)
Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
- Diabetes Care, Sep 02 2026, dc260757 | https://doi.org/10.2337/dc26-0757
- 2026-09
- 의약학
- 한빛사논문
Exposure to antibiotics during pregnancy or early infancy and the risk of autoimmune disease in children: A nationwide cohort study in Korea
- PLoS Med., Aug 2025, 22 (8) e1004677 | https://doi.org/10.1371/journal.pmed.1004677
- 2025-08
- 의약학
- 한빛사논문
- 배성호(Brigham and Women’s Hospital and Harvard Medical School)
Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Venous Thromboembolism
- JAMA Intern. Med., May 12 2025, | https://doi.org/10.1001/jamainternmed.2025.1109
- 2025-05
- 의약학
- 한빛사논문
- 배성호(Brigham and Women’s Hospital and Harvard Medical School)
[Brief Report] Opioid Overdose in Patients With Concomitant Use of Tramadol and Clopidogrel vs Alternative Antiplatelet Agents
- J. Am. Coll. Cardiol., 2024 Oct 15;84(16):1578-1581 | https://doi.org/10.1016/j.jacc.2024.07.036
- 2024-10
- 의약학
- 한빛사논문
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
- Gut, Sep 06 2024, gutjnl-2024-332687 | https://doi.org/10.1136/gutjnl-2024-332687
- 2024-09
- 의약학
- 한빛사논문
Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status
- JAMA Netw. Open, Dec 01 2023, 6 (12) | https://doi.org/10.1001/jamanetworkopen.2023.49856
- 2023-12
- 의약학
- 한빛사논문
Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes.
- JAMA Netw. Open, Sep 05 2023, 6 (9) | https://doi.org/10.1001/jamanetworkopen.2023.35797
- 2023-09
- 의약학
- 한빛사논문
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients with Type 2 Diabetes
- Clin. Gastroenterol. Hepatol., Available online 10 February 2023 | https://doi.org/10.1016/j.cgh.2023.01.031
- 2023-02
- 의약학
- 한빛사논문
Socioeconomic Disparities and Multidrug-Resistant Tuberculosis in South Korea: Focus on Immigrants and Income Levels
- J. Microbiol. Immunol. Infect., Available online 7 September 2022 | https://doi.org/10.1016/j.jmii.2022.08.014
- 2022-09
- 의약학
- 한빛사논문
Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
- Gut, First published June 20, 2022 | http://dx.doi.org/10.1136/gutjnl-2022-327504
- 2022-06
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기